New FDA Drug Doubles Survival for Pancreatic Cancer Patients @Wcpo9
New FDA Drug Doubles Survival for Pancreatic Cancer Patients @Wcpo9
Uploaded August 2026 | Updated September 2026, 2 weeks ago
UC researchers helped develop a new FDA-approved drug that doubles survival time for some pancreatic cancer patients, marking a major breakthrough in treatment.
New FDA Drug Doubles Survival for Pancreatic Cancer PatientsLoveland Launches Bird-Themed Scavenger Hunt Supporting CommunityFormer Superintendent, Contractor Indicted in Cincinnati School Fraud SchemeFlorence Officials Respond to Concerns Regarding Bowman Way Apartment ProjectWitnesses Recount What Led to the Shooting of 11-Year-old in East Price HillNew Nestlé Purina plant opens, bringing hundreds of jobs to Clermont CountyFranklin County Floodwaters Recede, Cleanup Efforts UnderwayPlaying out the clock | The Father Geoff Drew InvestigationFlood Devastates Lawrenceburg Family, Calls for Housing HelpBatavia Residents Cope with Second Day of Power OutageFriends Raise Money for Private Investigator After Ohio Man Shot in Puerto RicoCovington Independent School District welcomes graduates as new teachers
WCPO 9 |

New FDA Drug Doubles Survival for Pancreatic Cancer Patients

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER